KEYE TV |
Texas reaches settlement with drug manufacuturer over Alzheimer's medication claims
KEYE TV … representations about Abilify's risks by not revealing limitations that would substantially affect the interpretation of the scientific studies, saying BMS promoted Abilify to treat children and symptoms consistent with dementia and Alzheimer's … NH to receive $243K in Abilify drug settlement Bristol-Myers Squibb to pay $19.5 million to settle off-label promotion case Bristol-Myers Squibb reaches multistate settlement over Abilify |
